A Bioequivalence Study in Healthy Subjects Administered Evacetrapib Tablets of Varying Tablet Solid Fractions
Latest Information Update: 14 Jan 2020
At a glance
- Drugs Evacetrapib (Primary)
- Indications Atherosclerosis; Cardiovascular disorders; Dyslipidaemias
- Focus Pharmacokinetics
- Sponsors Eli Lilly and Company
- 08 Jan 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 30 Jul 2013 New trial record